A growing number of international life science companies are facing disputes regarding their cross-border Asian collaborations.

发言人:: James P. Duffy IV Milan Thakker 马修 黄美玲 殷之玥

活动类型: 研讨会, 网络研讨会

Reed Smith Richards Butler LLP, 18 Westlands Road, Quarry Bay 17th Floor, One Island East Taikoo Place, Hong Kong
17 November 2022, 4:30 PM CST
17 November 2022, 7:00 PM CST

These issues, might arise at every step of the pharmaceutical value chain. Those who are making investments should be aware of common pitfalls so that they can structure their investments accordingly. They should also be familiar with international arbitration, the resolution mechanism of choice for these disputes.

In this roundtable, our partners and external expert will discuss:

  • Structuring life sciences collaborations to minimise risk of disputes
  • What to do before and after a dispute arises
  • Why life sciences companies use international arbitration
  • Strategies for investments in China